Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

IIROC Trade Halt - Avivagen Inc.

Newsfile June 2, 2016

Avivagen Announces Presentation At Bloom Burton & Co. Conference on May 3, 2016

TheNewsWire May 2, 2016

Avivagen Announces Discovery of Counterparts of its Immunity-Enhancing Compounds In Numerous Common Human Foodstuffs

TheNewsWire April 26, 2016

Avivagen Announces CEO Update Important Developments Regarding Use of Antibiotics in Livestock Feeds

TheNewsWire April 26, 2016

Avivagen Announces Proposed Chinese Joint Venture to Commercialize OxC-Beta(tm) Livestock

TheNewsWire April 14, 2016

Avivagen Announces Voting Results for the Election of its Directors

TheNewsWire April 8, 2016

Avivagen Inc. Retains Renmark Financial Communications Inc.

TheNewsWire March 29, 2016

Avivagen Announces Results of Swine Trial With COFCO NHRI of the People's Republic of China

TheNewsWire March 22, 2016

Avivagen Announces Warrant Extension Exercise Life Extended by 4 Months Approved by the TSX Venture Exchange

TheNewsWire March 10, 2016

Avivagen Congratulates Board Member on Award David Allan Wins Life Sciences Ontario Special Award For Leadership

TheNewsWire February 24, 2016

Avivagen Announces Warrant Extension Exercise Life Extended by 4 Months

TheNewsWire February 18, 2016

Avivagen Announces Poultry Trial with UNAHCO, Inc. at the University of the Philippines Los Banos

TheNewsWire February 11, 2016

Avivagen Announces New E.U. Broiler Poultry Trial

TheNewsWire January 27, 2016

Avivagen Approves Advance Notice and Forum Selection By-Law

TheNewsWire January 21, 2016

Avivagen Announces Attendance at AlphaNorth Capital Conference January 16 & 17, 2016

TheNewsWire January 15, 2016

Avivagen Announces CEO Update Including OxC-beta(tm) Livestock Trial Results Versus Colistin

TheNewsWire January 8, 2016

Avivagen Announces Launch of New Website by its Chemaphor Chemical Services Division

TheNewsWire November 19, 2015

Avivagen Announces $1.0 million Drawdown Of its Credit Facility

TheNewsWire November 13, 2015

Avivagen Announces $1.8 million Credit Facility With the Bloom Burton Healthcare Lending Trust

TheNewsWire November 2, 2015

Avivagen Announces Swine Trial Agreement With COFCO NHRI of the People's Republic of China

TheNewsWire October 30, 2015